vs
帕可Bio（PACB）与Rumble Inc.（RUM）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是Rumble Inc.的1.6倍（$44.6M vs $27.1M），帕可Bio净利率更高（-90.4% vs -120.8%，领先30.4%），帕可Bio同比增速更快（13.8% vs -10.5%），帕可Bio自由现金流更多（$-19.9M vs $-31.7M），过去两年Rumble Inc.的营收复合增速更高（15.2% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
Rumble Inc.是一家加美跨国企业，主营在线视频平台、网络托管及云服务，总部位于加拿大多伦多，美国总部设在佛罗里达州朗博特基。公司由加拿大科技创业者克里斯·帕夫洛夫斯基于2013年创立，云服务板块为Truth Social提供托管支持，其视频平台在美国保守派及极右翼用户群体中广受欢迎，属于“另类科技”阵营。
PACB vs RUM — 直观对比
营收规模更大
PACB
是对方的1.6倍
$27.1M
营收增速更快
PACB
高出24.3%
-10.5%
净利率更高
PACB
高出30.4%
-120.8%
自由现金流更多
PACB
多$11.8M
$-31.7M
两年增速更快
RUM
近两年复合增速
7.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $27.1M |
| 净利润 | $-40.4M | $-32.7M |
| 毛利率 | 37.1% | 5.5% |
| 营业利润率 | -92.3% | -131.1% |
| 净利率 | -90.4% | -120.8% |
| 营收同比 | 13.8% | -10.5% |
| 净利润同比 | -1802.7% | 86.2% |
| 每股收益（稀释后） | $-0.11 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBRUM
| Q4 25 | $44.6M | $27.1M | ||
| Q3 25 | $38.4M | $24.8M | ||
| Q2 25 | $39.8M | — | ||
| Q1 25 | $37.2M | $23.7M | ||
| Q4 24 | $39.2M | $30.2M | ||
| Q3 24 | $40.0M | $25.1M | ||
| Q2 24 | $36.0M | $22.5M | ||
| Q1 24 | $38.8M | $17.7M |
净利润PACBRUM
| Q4 25 | $-40.4M | $-32.7M | ||
| Q3 25 | $-38.0M | $-16.3M | ||
| Q2 25 | $-41.9M | — | ||
| Q1 25 | $-426.1M | $-2.7M | ||
| Q4 24 | $2.4M | $-236.8M | ||
| Q3 24 | $-60.7M | $-31.5M | ||
| Q2 24 | $-173.3M | $-26.8M | ||
| Q1 24 | $-78.2M | $-43.3M |
毛利率PACBRUM
| Q4 25 | 37.1% | 5.5% | ||
| Q3 25 | 41.4% | -1.8% | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | -3.7% | -26.7% | ||
| Q4 24 | 25.6% | -14.2% | ||
| Q3 24 | 25.0% | -45.4% | ||
| Q2 24 | 16.5% | -58.8% | ||
| Q1 24 | 29.1% | -79.5% |
营业利润率PACBRUM
| Q4 25 | -92.3% | -131.1% | ||
| Q3 25 | -101.1% | -113.6% | ||
| Q2 25 | -112.8% | — | ||
| Q1 25 | -1154.5% | -153.5% | ||
| Q4 24 | -390.1% | -80.1% | ||
| Q3 24 | -160.3% | -131.0% | ||
| Q2 24 | -488.3% | -172.7% | ||
| Q1 24 | -209.6% | -197.4% |
净利率PACBRUM
| Q4 25 | -90.4% | -120.8% | ||
| Q3 25 | -98.9% | -65.7% | ||
| Q2 25 | -105.4% | — | ||
| Q1 25 | -1146.8% | -11.2% | ||
| Q4 24 | 6.0% | -783.2% | ||
| Q3 24 | -151.9% | -125.9% | ||
| Q2 24 | -481.3% | -119.2% | ||
| Q1 24 | -201.4% | -244.1% |
每股收益（稀释后）PACBRUM
| Q4 25 | $-0.11 | $-0.13 | ||
| Q3 25 | $-0.13 | $-0.06 | ||
| Q2 25 | $-0.14 | — | ||
| Q1 25 | $-1.44 | $-0.01 | ||
| Q4 24 | $-0.44 | $-1.17 | ||
| Q3 24 | $-0.22 | $-0.15 | ||
| Q2 24 | $-0.64 | $-0.13 | ||
| Q1 24 | $-0.29 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $237.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $274.8M |
| 总资产 | $784.1M | $336.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PACBRUM
| Q4 25 | $279.5M | $237.9M | ||
| Q3 25 | $298.7M | $269.8M | ||
| Q2 25 | $314.7M | — | ||
| Q1 25 | $343.1M | $301.3M | ||
| Q4 24 | $389.9M | $114.0M | ||
| Q3 24 | $471.1M | $132.0M | ||
| Q2 24 | $509.8M | $154.2M | ||
| Q1 24 | $561.9M | $183.8M |
股东权益PACBRUM
| Q4 25 | $5.3M | $274.8M | ||
| Q3 25 | $36.1M | $302.2M | ||
| Q2 25 | $61.5M | — | ||
| Q1 25 | $91.6M | $339.6M | ||
| Q4 24 | $506.6M | $-63.1M | ||
| Q3 24 | $453.1M | $166.1M | ||
| Q2 24 | $492.7M | $192.7M | ||
| Q1 24 | $649.0M | $210.7M |
总资产PACBRUM
| Q4 25 | $784.1M | $336.8M | ||
| Q3 25 | $803.2M | $367.2M | ||
| Q2 25 | $825.5M | — | ||
| Q1 25 | $860.8M | $391.1M | ||
| Q4 24 | $1.3B | $195.3M | ||
| Q3 24 | $1.5B | $217.2M | ||
| Q2 24 | $1.5B | $243.2M | ||
| Q1 24 | $1.7B | $263.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $-29.4M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $-31.7M |
| 自由现金流率自由现金流/营收 | -44.6% | -117.2% |
| 资本支出强度资本支出/营收 | 1.9% | 8.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $-70.8M |
8季度趋势，按日历期对齐
经营现金流PACBRUM
| Q4 25 | $-19.1M | $-29.4M | ||
| Q3 25 | $-18.7M | $-10.6M | ||
| Q2 25 | $-29.4M | — | ||
| Q1 25 | $-44.1M | $-14.5M | ||
| Q4 24 | $-30.6M | $-12.4M | ||
| Q3 24 | $-45.5M | $-19.1M | ||
| Q2 24 | $-54.3M | $-21.7M | ||
| Q1 24 | $-75.7M | $-33.9M |
自由现金流PACBRUM
| Q4 25 | $-19.9M | $-31.7M | ||
| Q3 25 | $-18.8M | $-12.0M | ||
| Q2 25 | $-29.9M | — | ||
| Q1 25 | $-45.4M | $-14.6M | ||
| Q4 24 | $-32.3M | $-12.4M | ||
| Q3 24 | $-46.3M | $-19.9M | ||
| Q2 24 | $-55.7M | $-23.1M | ||
| Q1 24 | $-79.6M | $-34.3M |
自由现金流率PACBRUM
| Q4 25 | -44.6% | -117.2% | ||
| Q3 25 | -48.9% | -48.6% | ||
| Q2 25 | -75.3% | — | ||
| Q1 25 | -122.3% | -61.7% | ||
| Q4 24 | -82.3% | -40.9% | ||
| Q3 24 | -115.7% | -79.5% | ||
| Q2 24 | -154.8% | -102.8% | ||
| Q1 24 | -205.0% | -193.3% |
资本支出强度PACBRUM
| Q4 25 | 1.9% | 8.5% | ||
| Q3 25 | 0.2% | 5.7% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 3.7% | 0.6% | ||
| Q4 24 | 4.1% | 0.1% | ||
| Q3 24 | 2.0% | 3.4% | ||
| Q2 24 | 4.1% | 6.1% | ||
| Q1 24 | 10.0% | 2.4% |
现金转化率PACBRUM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
